Ordering
Available Variants100 μg
CHA.81373-100μg
Price
€33.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 μg | CHA.81373-100μg | €33.60 |
≥95% (HPLC), 1 mg/mL in methyl acetate
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H28O3 |
|---|---|
| CAS Number | 87893-55-8 |
| Molecular Weight | 316.43 |
| NACRES | NA.77 |
| PubChem Substance ID | 329798863 |
| UNSPSC Code | 12352211 |
| EC Number | 201-185-2 |
| MDL number | MFCD00065806 |
| Assay | ≥95% (HPLC) |
| Form | liquid |
| Quality level | 200 |
Safety Information Handling visibility
| pictograms |
GHS02
GHS07
  GHS02,GHS07
|
|---|---|
| signalword | Danger |
| hcodes | H225,H319,H336 |
| pcodes | P210 - P233 - P240 - P241 - P242 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Flam. Liq. 2 - STOT SE 3 |
| target_organs | Central nervous system |
| supp_hazards | EUH066 |
| Storage Class | 3 - Flammable liquids |
| wgk | WGK 2 |
| flash_point_f | 15.8 °F - closed cup |
| flash_point_c | -9 °C - closed cup |
| ppe | Eyeshields, Faceshields, Gloves |
Technical Overview & Applications Use-case context
15-Deoxy-Δ12,14-prostaglandin J2, also known as 15-deoxy-PGJ2, is a prostaglandin J2 derivative with a CAS number of 87893-55-8. It is a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, which plays a crucial role in various cellular processes, including inflammation, cell proliferation, and differentiation. 15-Deoxy-PGJ2 has been shown to exhibit anti-inflammatory and anti-cancer properties, making it a potential therapeutic agent for the treatment of various diseases, including cancer and neurodegenerative disorders. Its mechanism of action involves the activation of PPARγ, which regulates the expression of genes involved in glucose and lipid metabolism, as well as inflammation. Further research is needed to fully understand the therapeutic potential of 15-deoxy-PGJ2 and its potential applications in the treatment of human diseases.
